Persistent monocyte activation and remodeling in people with HIV after 36 months of switching from a 3-drug regimen to B/F/TAF or DTG/3TC: a sub-study of the DEBATE trial.
- DOI
- 10.3389/fimmu.2026.1957183
- Published
- 2026
- Container
- Frontiers in immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2026.1957183,
title = {Persistent monocyte activation and remodeling in people with HIV after 36 months of switching from a 3-drug regimen to B/F/TAF or DTG/3TC: a sub-study of the DEBATE trial.},
author = {Santacroce E and Ciobanu AL and Gibellini L and Lo Tartaro D and De Biasi S and Gennari W and Roncaglia E and Beghetto B and Nardini G and Puzzolante C and Milic J and Cossarizza A and Mussini C},
year = {2026},
journal = {Frontiers in immunology},
doi = {10.3389/fimmu.2026.1957183},
url = {https://doi.org/10.3389/fimmu.2026.1957183}
}RIS
TY - JOUR TI - Persistent monocyte activation and remodeling in people with HIV after 36 months of switching from a 3-drug regimen to B/F/TAF or DTG/3TC: a sub-study of the DEBATE trial. AU - Santacroce E AU - Ciobanu AL AU - Gibellini L AU - Lo Tartaro D AU - De Biasi S AU - Gennari W AU - Roncaglia E AU - Beghetto B AU - Nardini G AU - Puzzolante C AU - Milic J AU - Cossarizza A AU - Mussini C PY - 2026 JO - Frontiers in immunology DO - 10.3389/fimmu.2026.1957183 UR - https://doi.org/10.3389/fimmu.2026.1957183 ER -
APA
E, S., AL, C., L, G., D, L. T., S, D. B., W, G., E, R., B, B., G, N., C, P., J, M., A, C., & C, M. (2026). Persistent monocyte activation and remodeling in people with HIV after 36 months of switching from a 3-drug regimen to B/F/TAF or DTG/3TC: a sub-study of the DEBATE trial.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1957183
Source records
- pubmed · retrieved 2026-11-10T11:53:00.687Z